Massachusetts General Hospital at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Massachusetts General Hospital brings 27 presentations to ASH 2026 in New Orleans. Its program spans transplant, immune thrombocytopenia and acute myeloid leukemia. It covers quality-of-life trajectories after transplant and corticosteroid use in persistent immune thrombocytopenia.
| Organization | ASH 2026 Attendance |
|---|---|
Massachusetts General Hospital Boston, MA | |
Harvard-affiliated teaching hospital in Boston and a founding member of the Mass General Brigham health system. | Symposium Fri Dec 11 7:00am–10:00am B-Cell–Directed Therapies in Immune Thrombocytopenia: Real-World Practice Newer B-cell-targeting treatments for immune thrombocytopenia and how to fit them into care to achieve lasting platelet responses. Symposium Fri Dec 11 7:00am–10:00am Current Management Paradigms in Acute Myeloid Leukemia – A Second Opinion Case Review Difficult acute myeloid leukemia cases where doctors sought second opinions, paired with reviews of recent data, current management, and ongoing trials. Symposium Fri Dec 11 3:00pm–6:00pm Immune Therapy for Myeloma: From CAR T and T-Cell Engagers to Community Care Sequencing CAR-T and T-cell engagers for relapsed myeloma, when to refer, managing toxicity, and options after B-cell maturation antigen therapy fails. Oral Sat Dec 12 9:30am–11:00am Oral Sat Dec 12 2:00pm–3:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Talk Sat Dec 12 6:00pm–8:00pm Talk Sun Dec 13 4:30pm–5:45pm Emerging Therapies for Treatment of Hereditary Hemolytic Anemias New treatments beyond transfusion and spleen removal for inherited hemolytic anemias outside hemoglobin disorders, from pyruvate kinase activators to gene repair. Session Sun Dec 13 4:30pm–5:45pm Hemolysis Beyond Globin: Managing Inherited RBC Membrane and Enzyme Disorders Genetic diagnosis of inherited red cell membrane and enzyme disorders, and treatment with pyruvate kinase activators, stem cell transplant or gene therapy. Oral Sun Dec 13 4:30pm–6:00pm Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Oral Mon Dec 14 10:30am–12:00pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm |
Find decision makers at Massachusetts General Hospital
Tell us what you sell and we’ll find the people at Massachusetts General Hospital most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction